Thomas J. Schaefer - 03 Jan 2023 Form 3 Insider Report for Arcadia Biosciences, Inc. (RKDA)

Role: Chief Financial Officer
Signature: Thomas Schaefer, by Attorney-in-fact, Solaeta Chan
Issuer symbol: RKDA
Transactions as of: 03 Jan 2023
Net transactions value: $0
Form type: 3
Filing time: 05 Jan 2023, 19:47:21 UTC
Next filing: 02 Feb 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	RKDA	Common Stock						2,100	03 Jan 2023	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	RKDA	Stock Option (Right to Buy)							03 Jan 2023	Common Stock	8,000	$3.67	Direct	F1
holding	RKDA	Stock Option (Right to Buy)							03 Jan 2023	Common Stock	4,000	$3.05	Direct	F2
holding	RKDA	Stock Option (Right to Buy)							03 Jan 2023	Common Stock	20,000	$2.09	Direct	F3
holding	RKDA	Stock Option (Right to Buy)							03 Jan 2023	Common Stock	23,000	$1.27	Direct	F4
holding	RKDA	Stock Option (Right to Buy)							03 Jan 2023	Common Stock	31,000	$1.27	Direct	F5
holding	RKDA	Stock Option (Right to Buy)							03 Jan 2023	Common Stock	23,000	$0.9400	Direct	F6

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The options were granted on 7/27/2020 and the vesting occurs as follows, subject to the Participant's continued service: (1) 25% of the shares vest on the first anniversary of the date of the award and (2) 75% of the shares vest in 36 equal installments, the first installment occurring on the last day of the month in which the initial vesting date occurs.
F2	The options were granted on 1/21/2021 and the vesting occurs as follows, subject to the Participant's continued service: (1) 25% of the shares vest on the first anniversary of the date of the award and (2) 75% of the shares vest in 36 equal installments, the first installment occurring on the last day of the month in which the initial vesting date occurs.
F3	The options will vest monthly in equal installments over a period of four years from the date of the grant, 10/1/2021, subject to the Participant's continued service.
F4	The options will vest annually in equal installments over a period of two years from the date of the grant, 4/11/2022, subject to the Participant's continued service.
F5	The options were granted on 4/11/2022 and the vesting occurs as follows, subject to the Participant's continued service: (1) 25% of the shares vest on the first anniversary of the date of the award and (2) 75% of the shares vest in 36 equal installments, the first installment occurring on the last day of the month in which the initial vesting date occurs.
F6	The options will vest annually in equal installments over a period of three years from the date of the grant, 8/16/2022, subject to the Participant's continued service.